Photodynamic Therapy and Hyperthermia in Combination Treatment-Neglected Forces in the Fight against Cancer

被引:29
作者
Bienia, Aleksandra [1 ]
Wiechee-Cudak, Olga [1 ]
Murzyn, Aleksandra Anna [1 ]
Krzykawska-Serda, Martyna [1 ]
机构
[1] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland
关键词
photodynamic therapy (PDT); hyperthermia; chemotherapy; radiotherapy; surgical intervention; cancer; combination therapy; hypoxia; drug delivery; CELL LUNG-CANCER; PHASE-II TRIAL; TRIPLE-MODALITY TREATMENT; INTRAPERITONEAL CHEMOTHERAPY; COLORECTAL-CANCER; CYTOREDUCTIVE SURGERY; DRUG-DELIVERY; OPEN-LABEL; LOCAL HYPERTHERMIA; PROSTATE-CANCER;
D O I
10.3390/pharmaceutics13081147
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer is one of the leading causes of death in humans. Despite the progress in cancer treatment, and an increase in the effectiveness of diagnostic methods, cancer is still highly lethal and very difficult to treat in many cases. Combination therapy, in the context of cancer treatment, seems to be a promising option that may allow minimizing treatment side effects and may have a significant impact on the cure. It may also increase the effectiveness of anti-cancer therapies. Moreover, combination treatment can significantly increase delivery of drugs to cancerous tissues. Photodynamic therapy and hyperthermia seem to be ideal examples that prove the effectiveness of combination therapy. These two kinds of therapy can kill cancer cells through different mechanisms and activate various signaling pathways. Both PDT and hyperthermia play significant roles in the perfusion of a tumor and the network of blood vessels wrapped around it. The main goal of combination therapy is to combine separate mechanisms of action that will make cancer cells more sensitive to a given therapeutic agent. Such an approach in treatment may contribute toward increasing its effectiveness, optimizing the cancer treatment process in the future.
引用
收藏
页数:48
相关论文
共 405 条
  • [1] New photosensitizers for photodynamic therapy
    Abrahamse, Heidi
    Hamblin, Michael R.
    [J]. BIOCHEMICAL JOURNAL, 2016, 473 : 347 - 364
  • [2] Ackroyd R, 2001, PHOTOCHEM PHOTOBIOL, V74, P656, DOI 10.1562/0031-8655(2001)074<0656:THOPAP>2.0.CO
  • [3] 2
  • [4] Phase Ib/II study of ALT-803 in combination with gemcitabine and nab-paclitaxel in patients with advanced pancreatic cancer.
    Acoba, Jared David
    Rock, Amy
    Wong, Hing C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [5] Photodynamic therapy using graphene quantum dot derivatives
    Ahirwar, Satyaprakash
    Mallick, Sudhanshu
    Bahadur, Dhirendra
    [J]. JOURNAL OF SOLID STATE CHEMISTRY, 2020, 282
  • [6] Ahmed K, 2013, J PAK MED ASSOC, V63, P504
  • [7] Ahn, 2016, PEMETREXED ERLOTINIB
  • [8] Al-Tweigeri, 2015, STUDY SAFETY EFFICAC
  • [9] Alanazi Fars K, 2010, Saudi Pharm J, V18, P179, DOI 10.1016/j.jsps.2010.07.002
  • [10] Oxidative Stress and Photodynamic Therapy of Skin Cancers: Mechanisms, Challenges and Promising Developments
    Allegra, Alessandro
    Pioggia, Giovanni
    Tonacci, Alessandro
    Musolino, Caterina
    Gangemi, Sebastiano
    [J]. ANTIOXIDANTS, 2020, 9 (05)